METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer: combo therapy enters phase 3 trial
Disease control Not yet recruitingThis phase 3 trial tests whether adding the experimental drug chiauranib and an immunotherapy (toripalimab) to standard chemotherapy can help people with metastatic pancreatic cancer live longer. About 558 adults who have not had prior treatment for their advanced cancer will tak…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for pancreatic cancer: experimental drug combo enters large trial
Disease control Not yet recruitingThis study tests a new drug, telisotuzumab adizutecan, combined with standard chemotherapy (FOLFOX) in people with metastatic pancreatic cancer that has spread. About 900 adults will receive either the new combination or standard care. The goal is to see if the new treatment shri…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Migraine medicine takes on pancreatic cancer in new trial
Disease control Not yet recruitingThis study tests whether adding the migraine drug rimegepant to standard chemotherapy (AG) can help control metastatic pancreatic cancer. About 30 adults who have not had prior treatment for their cancer will receive the combination. The goal is to see if it delays disease progre…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xiuchao Wang • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
New hope for tough-to-treat pancreatic cancer? drug combo enters first human tests
Disease control Not yet recruitingThis early-phase trial tests a combination of two drugs, cosibelimab and balixafortide, in 24 adults with metastatic pancreatic cancer that has worsened after standard chemotherapy. The main goal is to find the safest dose and check for side effects. This is not a cure, but aims …
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Arsen Osipov • Aim: Disease control
Last updated May 06, 2026 16:02 UTC